A study by Sotiriou et al [71] observed that low and high genetic grades can segregate patients with PR+ tumours according to endocrine responsiveness and cell proliferation, whereas the low genetic grade has lower proliferation and greater endocrine responsiveness. Here, PGR is linked to neoplasm.